Premier, Inc. (NASDAQ: PINC), a leading technology-driven healthcare improvement company, today reported financial results for the fiscal-year 2025 second quarter ended December 31, 2024.

Ms. Fogarty has served at Tonix since 2016, most recently as Executive Vice President, Product DevelopmentTonix is Preparing for Potential Launch ...

All participants will be in listen-only mode. After today's presentation, there will be an opportunity to ask questions. [Operator instructions] Please note, today's event is being recorded. I would ...

Detailed price information for Tonix Pharm Holdings (TNXP-Q) from The Globe and Mail including charting and trades.

Welcome to the Merck & Company Q4 sales and earnings conference call. [Operator instructions] This call is being recorded.

Q2 2025 Earnings Call February 4, 2025 8:00 AM ETCompany ParticipantsBen Krasinski - Senior Director, IRMichael J.

Soligenix, Inc. (Soligenix or the Company), a late-stage biopharmaceutical company focused on developing and commercializing products to treat rare diseases where there is an unmet medical ...

The Western Union Company ( NYSE: WU) Q4 2024 Results Conference Call February 4, 2025 4:30 PM ET Tom Hadley - Vice President of Investor Relations Devin McGranahan - Chief Executive Officer Matt ...

X300 Series, a Cellular Compact IoT Gateway Solution that includes Lantronix's IoT gateway hardware and centralized device ...

Ms. Fogarty has served at Tonix since 2016, most recently as Executive Vice President, Product Development Tonix is Preparing for Potential Launch of TNX-102 SL for the management of fibromyalgia with ...

Inflection Point Fund and other related investors, including Chairman Michael Blitzer, increase their PIPE investments by $15.25 million, ...

Fabrinet (NYSE: FN), a leading provider of advanced optical packaging and precision optical, electro-mechanical and electronic manufacturing services to original ...